Severe Idiopathic Hypereosinophilic Syndrome with Eosinophilic Cholecystitis in a Child Treated with Mepolizumab

被引:0
作者
Jin, Jing [1 ]
Yu, Haiguo [1 ]
机构
[1] Nanjing Med Univ, Dept Rheumatol & Immunol, Childrens Hosp, Nanjing, Peoples R China
关键词
D O I
10.1007/s12098-023-05007-8
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
引用
收藏
页码:117 / 118
页数:2
相关论文
共 4 条
[1]   Efficacy and safety of mepolizumab in hypereosinophilic syndrome: A phase III, randomized, placebo-controlled trial [J].
Roufosse, Florence ;
Kahn, Jean-Emmanuel ;
Rothenberg, Marc E. ;
Wardlaw, Andrew J. ;
Klion, Amy D. ;
Kirby, Suyong Yun ;
Gilson, Martyn J. ;
Bentley, Jane H. ;
Bradford, Eric S. ;
Yancey, Steven W. ;
Steinfeld, Jonathan ;
Gleich, Gerald J. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 146 (06) :1397-1405
[2]   World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management [J].
Shomali, William ;
Gotlib, Jason .
AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (01) :129-148
[3]   Laboratory Diagnosis of Antiphospholipid Syndrome in Anticoagulated Patients [J].
Tripodi, Armando ;
Scalambrino, Erica ;
Clerici, Marigrazia ;
Peyvandi, Flora .
BIOMEDICINES, 2023, 11 (06)
[4]  
Yalcin F, 2014, J PAK MED ASSOC, V64, P1191